Your browser doesn't support javascript.
loading
Outcome of relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: a North American analysis.
Strati, Paolo; Cheng, Phoebe T M; Steiner, Raphael E; Alcedo Andrade, Pedro E; Feng, Lei; Sano, Dahlia; Rao, Veeramaneni A; Singh, Prachee; Miranda, Roberto; Gunther, Jillian R; Pinnix, Chelsea C; Dabaja, Bouthaina S; Cuglievan, Branko; Xing, Katharine; Villa, Diego; Skinnider, Brian; Sehn, Laurie H; Connors, Joseph M; Nieto, Yago; Ahmed, Sairah; Lee, Hun J; Savage, Kerry J.
Afiliação
  • Strati P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cheng PTM; BC Cancer Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Steiner RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Alcedo Andrade PE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sano D; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Rao VA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Singh P; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Miranda R; Department of Hemato-Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gunther JR; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pinnix CC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Dabaja BS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cuglievan B; Department of Pediatric Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Xing K; Department of Medical Oncology, British Columbia Cancer Center, Vancouver, BC, Canada.
  • Villa D; BC Cancer Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Skinnider B; Department of Pathology, British Columbia Cancer Center, Vancouver, BC, Canada.
  • Sehn LH; BC Cancer Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Connors JM; BC Cancer Centre for Lymphoid Cancer and Department of Medical Oncology, BC Cancer, Vancouver, BC, Canada.
  • Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ahmed S; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lee HJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Savage KJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Br J Haematol ; 192(3): 560-567, 2021 02.
Article em En | MEDLINE | ID: mdl-33517581

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Recidiva Local de Neoplasia Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Br J Haematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Recidiva Local de Neoplasia Limite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged País/Região como assunto: America do norte Idioma: En Revista: Br J Haematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido